How will the new EU General Data Protection Regulation (GDPR) affect my clinical trial?
The European medical regulatory landscape is undergoing its most significant overhaul in years. The eagerly-awaited Medical Device Regulation (MDR), published in May 2017, will bring substantial changes to the way medical device manufacturers bring their devices into the European market. Download this white paper and discover nine important factors for the successful planning, development and maintenance of a Clinical Evaluation Report (CER).
The UK’s Medicines & Healthcare products Regulatory Agency will continue to recognize CE Marked products for use in the country for a limited time following a ‘no deal’ Brexit scenario, according to new guidance from the agency.
Whether you are a first-time inventor or a large manufacturer, the thrill of bringing a medical device to market is both exhilarating and overwhelming. The development of a successful device not only requires optimized design efforts, but also clinical, regulatory & marketing expertise. Download this 30 min. webinar and increase your chances of successfully launching your medical device.
Medical Device Manufacturers benefit from the partnership between genae and MedicSense as we now can provide pre- to post regulatory and quality expertise in addition to clinical trial management and digital health services. Download this info sheet and discover all facts & figures about our Israeli expertise.
By when do I need to update the Clinical Evaluation Report?
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) released today a business plan for the upcoming year, noting its primary focus on developing a consensus around a proposed model for the future of the country’s regulation of medicines and medical devices following its departure from the EU.
Which medical devices fall under the EU MDR scope?
Which country should I go to for my clinical trial?